NCT07595757

Brief Summary

This randomized controlled clinical trial aims to evaluate the effectiveness of using nano-hyaluronic acid (nano-HyA) gel alongside a minimally invasive non-surgical technique (MINST) to treat deep intrabony defects in patients with Stage II and III periodontitis. While MINST is a proven method for cleaning deep periodontal pockets without the need for traditional surgery , the addition of nano-HyA may further enhance soft tissue healing, reduce inflammation, and promote regeneration. Participants in the study will be randomly assigned to one of two groups. The test group will receive the MINST procedure combined with the application of nano-HyA gel into the periodontal pocket, while the control group will receive the MINST procedure alone. The primary goal of the study is to measure the decrease in probing pocket depth over a 6-month follow-up period to determine if the adjunctive use of nano-HyA provides superior clinical and radiographic outcomes compared to non-surgical treatment alone

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at P25-P50 for phase_1

Timeline
4mo left

Started Jul 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Jul 2025Aug 2026

Study Start

First participant enrolled

July 15, 2025

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 11, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 19, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 29, 2026

Last Updated

May 19, 2026

Status Verified

May 1, 2026

Enrollment Period

1 year

First QC Date

May 11, 2026

Last Update Submit

May 15, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pocket Depth (PD)

    Measured in millimeters (mm) from the gingival margin to the bottom of the gingival sulcus using a UNC-15 periodontal probe. Each tooth is probed at 6 sites with a light force not exceeding 25 grams.

    "From enrollment to the end of treatment at 24 weeks"

Secondary Outcomes (7)

  • Full-Mouth Plaque Score (FMPS)

    From enrollment to the end of treatment at 24 weeks

  • Full-Mouth Bleeding Score (FMBS)

    From enrollment to the end of treatment at 24 weeks

  • Clinical Attachment Level (CAL)

    From enrollment to the end of treatment at 24 weeks

  • Gingival Recession (GR)

    From enrollment to the end of treatment at 24 weeks

  • Radiographic Defect Angle (RDA)

    From enrollment to the end of treatment at 24 weeks

  • +2 more secondary outcomes

Study Arms (2)

MINST alone

ACTIVE COMPARATOR

Participants receive the minimally invasive non-surgical technique (MINST) alone without adjunctive treatment

Procedure: Minimally invasive non-surgical technique (MINST)

MINST + nano-hyaluronic acid

EXPERIMENTAL

Participants receive MINST combined with adjunctive nano-hyaluronic acid

Procedure: Minimally invasive non-surgical technique (MINST)Biological: nano-hyaluronic acid

Interventions

Subgingival debridement using thin ultrasonic tips and additional instrumentation with Gracey mini-curettes, deliberately avoiding subgingival rinsing to support blood clot stabilization

MINST + nano-hyaluronic acidMINST alone

Pockets associated with intrabony defects are filled with nano-HyA paste immediately after subgingival debridement

MINST + nano-hyaluronic acid

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females aged ≥ 18 years.
  • Patients with a diagnosis of periodontitis (stage II or III).
  • At least one tooth with ≥5 mm PPD and CAL and evidence of radiographic bone loss.
  • Presenting with at least 1 intrabony defect, with a radiographic intra-bony component ≥3 mm.

You may not qualify if:

  • Patients with systemic diseases.
  • Pregnant or lactating females.
  • Tobacco smokers (≥ 10 cigarettes per day).
  • Multi-rooted teeth with class II and class III furcation defects.
  • Third molars.
  • Teeth with grade III mobility.
  • Peri-apical pathology and acute abscess.
  • Non-surgical or surgical periodontal treatment in the past 12 months.
  • Prolonged treatment with antibiotics or anti-inflammatory agents within 6 months before periodontal therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Cairo University

Cairo, Cairo Governorate, Egypt

Location

MeSH Terms

Conditions

Periodontal DiseasesPeriodontitis

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master's student, Periodontology

Study Record Dates

First Submitted

May 11, 2026

First Posted

May 19, 2026

Study Start

July 15, 2025

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 29, 2026

Last Updated

May 19, 2026

Record last verified: 2026-05

Locations